DaVita
DVA
#1820
Rank
NZ$20.49 B
Marketcap
NZ$321.20
Share price
0.42%
Change (1 day)
44.59%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): NZ$18.80

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$19.22. In 2025 the company made an earnings per share (EPS) of NZ$17.68 a decrease over its 2024 EPS that were of NZ$19.27.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$18.806.33%
2025NZ$17.68-8.25%
2024NZ$19.2744.94%
2023NZ$13.2927.26%
2022NZ$10.45-35.56%
2021NZ$16.2144.1%
2020NZ$11.2519.7%
2019NZ$9.40540.48%
2018NZ$1.47-76.07%
2017NZ$6.13-19.31%
2016NZ$7.60242.52%
2015NZ$2.22-62.87%
2014NZ$5.9713.43%
2013NZ$5.278.45%
2012NZ$4.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
NZ$42.47 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$19.85 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
NZ$33.87 76.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.61-81.20%๐Ÿ‡บ๐Ÿ‡ธ USA